Evaluation of Iphone Technology in Diabetes Treatment
1 other identifier
interventional
43
1 country
1
Brief Summary
Background With the emergence of the internet, health care professionals are changing the way they approach diabetes management. Internet Blood Glucose Monitoring Systems (IBGMS) are aimed at keeping blood glucose levels normal or in the range of acceptable levels to prevent the complications associated with diabetes. The Principal Investigators have completed a randomized clinical trial supporting the efficacy of IBGMS (1,2). Patient satisfaction of reporting platform is essential to encourage patient reporting and participation in IBGMS. In this study, we wish to compare two different types of meters which will be used to internet blood glucose monitoring: the BG Star Meter (Conventional Meter), and the iBG Star Group (iPhone Technology). Purpose and Rationale Patients who are more satisfied with their meter and internet reporting platform are more likely to participate in an internet monitoring system. Patients often lack the motivation to report to their endocrinologist. With increased reporting to their healthcare professional, patients are more likely to benefit from such a system. This study aims to compare two types of meters and their respective internet reporting platforms to encourage patient participation. Objectives Our main goal is to compare the two types of meters. Primary Outcomes Include:
- Type 1s
- Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet Access Exclusion criteria: Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Apr 2013
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2013
CompletedFirst Posted
Study publicly available on registry
March 25, 2013
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedDecember 5, 2014
December 1, 2014
8 months
March 21, 2013
December 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Patient Satisfaction
6 months
Frequency of SMBG testing
6 months
Frequency of Reporting
How often patient sends report in to endocrinologist
6 months
Time required to teach meter/internet platform
Measured at beginning of study
Study Arms (2)
BG Star (Conventional Meter)
ACTIVE COMPARATOR25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
IBG Star Group (iPhone)
ACTIVE COMPARATOR25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Interventions
Patients in BG Star Meter Group will report using BG software through uploading information onto a computer and sending readings to their endocrinologist via email
25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Eligibility Criteria
You may qualify if:
- Type 1s
- Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet Access
You may not qualify if:
- Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endocrine Research Society
Vancouver, British Columbia, V6E1M7, Canada
Related Publications (1)
Tildesley HD, Mazanderani AB, Ross SA. Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulin. Diabetes Care. 2010 Aug;33(8):1738-40. doi: 10.2337/dc09-2256.
PMID: 20668152RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 21, 2013
First Posted
March 25, 2013
Study Start
April 1, 2013
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
December 5, 2014
Record last verified: 2014-12